PortfoliosLab logoPortfoliosLab logo

ProShares Ultra Nasdaq Biotechnology (BIB) belongs to the Leveraged Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with BIB. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to BIB

BIB charges 0.95% annually. There are 97 ETFs in the Leveraged Equities category with lower expense ratios, going as low as 0.35%.


Best Risk-Adjusted Alternatives to BIB

BIB has a PortfoliosLab risk / return rank of 86. There are 19 ETFs in the Leveraged Equities category with higher risk-adjusted ranks, going as high as 98.


Top Performing BIB Alternatives (YTD)

BIB is at 20.44% YTD. There are 111 ETFs in the Leveraged Equities category with higher YTD returns, going as high as 699.96%.


Lowest Volatility Alternatives to BIB

BIB has 40.61% 1-year volatility. There are 81 ETFs in the Leveraged Equities category with lower 1-year volatility, going as low as 4.89%.


Lowest Drawdown Alternatives to BIB

BIB has a 1-year max drawdown of -16.92%. There are 14 ETFs in the Leveraged Equities category with shallower 1-year drawdowns, going as shallow as -1.72%.


Other ETFs from ProShares

The 10 most viewed ProShares ETFs shown here include TQQQ, QLD, BITO and span 10 categories. AUM among these funds goes as high as $33B.


Often Compared With BIB

Investors most often compare BIB with XBI, LABU, BIS. These 20 comparison targets span 11 categories, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
SPDR S&P Biotech ETFHealth & Biotech Equities
93
20.93%
9.90BFeb 2006BIB vs XBI
Direxion Daily S&P Biotech Bull 3x SharesLeveraged Equities
94
43.07%
543.30MMay 2015BIB vs LABU
ProShares UltraShort Nasdaq BiotechnologyLeveraged Equities
1
-24.30%
2.32MApr 2010BIB vs BIS
VanEck Biotech ETFHealth & Biotech Equities
56
7.93%
399.88MDec 2011BIB vs BBH
Amgen Inc.
77
17.43%
BIB vs AMGN
Invesco Nasdaq Biotechnology ETFHealth & Biotech Equities
89
12.90%
75.06MJun 2021BIB vs IBBQ
ARK Genomic Revolution Multi-Sector ETFHealth & Biotech Equities, Actively Managed
63
36.76%
1.73BOct 2014BIB vs ARKG
State Street SPDR S&P 500 ETFS&P 500
78
11.70%
789.06BJan 1993BIB vs SPY
Nasdaq, Inc.
42
-2.42%
BIB vs NDAQ
ProShares Ultra Health CareLeveraged Equities
58
6.87%
84.21MJan 2007BIB vs RXL
YieldMax RDDT Option Income Strategy ETFDerivative Income
-28.64%
15.14MSep 2025BIB vs RDYY
Virtus LifeSci Biotech Clinical Trials ETFHealth & Biotech Equities
96
27.03%
47.80MDec 2014BIB vs BBC
Invesco DWA Healthcare Momentum ETFMomentum, Health & Biotech Equities
89
16.97%
235.21MOct 2006BIB vs PTH
Direxion Daily Pharmaceutical & Medical Bull 3X Sh...Leveraged Equities
95
54.54%
22.43MNov 2017BIB vs PILL
Vanguard Total Stock Market ETFLarge Cap Blend Equities
78
12.18%
2.30TMay 2001BIB vs VTI
Direxion Daily MSCI South Korea Bull 3X SharesSouth Korea Equities, Leveraged Equities, Asia Pacific Equities
84
74.82%
1.38BApr 2013BIB vs KORU
GraniteShares 2x Long MRVL Daily ETFLeveraged Equities
66
201.58%
237.42MMar 2025BIB vs MVLL
Amplify Blockchain Technology ETFBlockchain, Technology Equities
17
7.85%
1.06BJan 2018BIB vs BLOK
Coeur Mining, Inc.
74
-12.63%
BIB vs CDE
Leverage Shares 2X Long AMD Daily ETFLeveraged Equities
87
241.41%
27.10MJan 2025BIB vs AMDG

Compare BIB with Any Fund or Stock

Compare BIB with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair BIB with funds that move differently

ProShares Ultra Nasdaq Biotechnology alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to BIB.

Explore BIB Diversifiers